Sustaining and transitioning mpox vaccination requires establishing and resourcing a global mpox vaccine stockpile under the Inter-Agency Coordinating Group (ICG), supported by sustainable financing, transparent allocation criteria, diversified manufacturing (including local production in Africa), and robust logistics, surveillance, and operational systems. Moreover, it requires strengthened collaboration among global, regional, and community actors; continuous data generation and research to inform policy, including genomic and vaccine effectiveness studies; and accelerated R&D with fast-tracked local manufacturing to enhance supply resilience and long-term epidemic preparedness.
- Yap Boum
- Reena H. Doshi
- Rosamund F. Lewis